| Unknown | AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC Unresectable Esophageal Squamous Cell Carcinoma, Locally Advanced Esophageal Squamous Cell Carcinoma, Metastatic Esophageal Squamous Cell Carcinoma | Phase 2 | 2022-10-01 |
| Unknown | A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Advanced Tumor of Digestive Tract or Urinary System | Phase 1 | 2022-09-30 |
| Unknown | FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage Colorectal Neoplasms Malignant | Phase 2 | 2022-08-12 |
| Not Yet Recruiting | Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer Rectal Neoplasms Malignant, Radiotherapy | Phase 2 / Phase 3 | 2022-08-06 |
| Unknown | Low-dose Radiotherapy in iNHL Indolent Lymphoma, Low-dose Radiotherapy | Phase 2 | 2022-05-01 |
| Unknown | Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection Esophageal Cancer | — | 2022-04-23 |
| Unknown | Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2022-04-12 |
| Unknown | Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technolo Breast Cancer | — | 2022-04-01 |
| Unknown | Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breas Breast Cancer | Phase 4 | 2022-03-12 |
| Unknown | A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma Carcinoma, Transitional Cell, HER-2 Gene Amplification | Phase 2 | 2022-03-10 |
| Not Yet Recruiting | Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study Breast Cancer | N/A | 2022-03-01 |
| Unknown | Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults SARS-CoV-2 Infection | Phase 3 | 2022-02-18 |
| Unknown | Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer HER2-positive Breast Cancer | Phase 2 | 2022-01-01 |
| Unknown | Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on SARS-CoV-2 Infection | Phase 3 | 2021-12-18 |
| Unknown | Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults SARS-CoV2 Infection | Phase 3 | 2021-12-16 |
| Unknown | Comparative Effectiveness of PAL Based-therapy as Initial ET Versus PAL Based-therapy After ChT for HR+/HER2- Hormone Receptor Positive Advanced Breast Cancer | — | 2021-12-01 |
| Unknown | Characteristics and Treatment Trends of Young Breast Cancer in China Breast Cancer | — | 2021-11-01 |
| Unknown | Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type, Early-stage, High-Risk Cancer | Phase 2 | 2021-10-01 |
| Unknown | Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBC DLBCL, MYD88 Gene Mutation, CD79A Gene Mutation | Phase 2 | 2021-10-01 |
| Unknown | Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL Early-stage, Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | 2021-10-01 |
| Unknown | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT m Colo-rectal Cancer | Phase 3 | 2021-09-06 |
| Unknown | Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABC Hormone Receptor Positive Advanced Breast Cancer | — | 2021-09-01 |
| Unknown | Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma Leiomyosarcoma | N/A | 2021-08-27 |
| Unknown | Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab a Advanced Breast Cancer | Phase 2 | 2021-08-20 |
| Enrolling By Invitation | Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage I Non-small Cell Lung Carcinoma | Phase 3 | 2021-08-01 |
| Completed | Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China Esophageal Neoplasms | — | 2021-06-01 |
| Unknown | Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squ HNSCC | Phase 2 | 2021-06-01 |
| Unknown | Real World Study of MPM in China Malignant Pleural Mesothelioma, Diagnoses Disease, Treatments | — | 2021-06-01 |
| Unknown | TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydro Patients With Resectable Hepatocellular Carcinoma Who Are at High Risk of Recurrence or Metastasi | Phase 1 / Phase 2 | 2021-04-30 |
| Unknown | Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction Breast Carcinoma | N/A | 2021-04-08 |
| Recruiting | Radiotherapy for Extracranial Oligometastatic Breast Cancer Breast Cancer Metastatic | Phase 3 | 2021-04-06 |
| Unknown | Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC Small-cell Lung Cancer | Phase 2 | 2021-04-01 |
| Unknown | A Study of Camrelizumab Plus Apatinib as Consolidation Therapy in Non-Small Cell Lung Cancer Patients Treated Locally Advanced Non-Small Cell Lung Cancer | Phase 2 | 2021-03-17 |
| Unknown | Radiotherapy Plus Durvalumab in Elderly Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma | N/A | 2021-03-11 |
| Completed | Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection Esophageal Cancer | — | 2021-03-01 |
| Unknown | The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-1 COVID-19 | Phase 3 | 2021-01-28 |
| Unknown | Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. Ovarian Cancer | Phase 2 | 2020-12-09 |
| Unknown | Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection Rotavirus Infection | Phase 1 | 2020-12-03 |
| Unknown | The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs Nausea, Vomiting, Head and Neck Squamous Cell Carcinoma | Phase 2 | 2020-12-01 |
| Completed | The Clinical Effect of Adaptive Posture-balance Cardiac Rehabilitation Exercise on Cardiovascular Diseases Cardiac Rehabilitation, Exercise Therapy, Balance Exercises | N/A | 2020-12-01 |
| Unknown | Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy Brain Death, Coma | — | 2020-11-10 |
| Unknown | Tislelizumab in Combination With Anlotinib With ES-SCLC as Maintenance Therapy After First Line Chemotherapy Small Cell Lung Carcinoma | Phase 2 | 2020-11-01 |
| Unknown | Prophylactic Cranial Irradiation in Extensive-stage Small Cell Lung Cancer Extensive-stage Small-cell Lung Cancer | — | 2020-11-01 |
| Unknown | Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study Advanced Colorectal Cancer | — | 2020-10-01 |
| Unknown | Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer Triple Negative Breast Cancer | Phase 2 | 2020-09-23 |
| Unknown | The Study of Exosome EML4-ALK Fusion in NSCLC Clinical Diagnosis and Dynamic Monitoring Untreated Advanced NSCLC Patients, FISH Identified ALK Fusion Positive or Negative | — | 2020-08-01 |
| Enrolling By Invitation | Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL Diffuse Large B Cell Lymphoma | — | 2020-07-01 |
| Unknown | A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS Sarcoma | Phase 2 | 2020-07-01 |
| Unknown | Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lym Diffuse Large B-cell Lymphoma, Rituximab, Toripalimab | Phase 2 | 2020-06-15 |
| Completed | Comparison of Two Bending Angles for Nasotracheal Intubation With a Malleable Vedio Stylet Intubation;Difficult | N/A | 2020-06-04 |
| Unknown | Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Triple Negative Breast Cancer | Phase 2 | 2020-06-01 |
| Unknown | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Eso Esophageal Squamous Cell Carcinoma | Phase 2 | 2020-05-15 |
| Suspended | A Real-world Clinical Study of Kapok Initiative Quality of Life | N/A | 2020-05-08 |
| Unknown | A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer Metastatic Cancer, Colorectal Cancer, Colorectal Adenocarcinoma | Phase 1 / Phase 2 | 2020-04-26 |
| Unknown | Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC Non Small Cell Lung Cancer, Stage III Non-small-cell Lung Cancer, EGFR Mutation-Related Tumors | — | 2020-03-01 |
| Unknown | Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer HER2-positive Breast Cancer | — | 2020-02-28 |
| Recruiting | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemo Triple Negative Breast Cancer | Phase 2 | 2020-02-01 |
| Unknown | Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma Esophageal Squamous Cell Carcinoma | Phase 2 | 2020-01-20 |
| Unknown | HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC Breast Cancer | Phase 2 | 2020-01-01 |
| Unknown | Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer Breast Cancer | Phase 2 | 2019-12-28 |
| Unknown | Hemodynamic Changes During Dry Cupping Therapy on Low Back Pain Oxygen Metabolism, Muscle Spasticity | N/A | 2019-12-01 |
| Unknown | Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. Diffuse Large B-Cell Lymphoma, Sintilimab, TP53 Mutation | Phase 2 | 2019-12-01 |
| Unknown | Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Aden Advanced Gastric and Gastro-esophageal Junction Adenocarcinoma | Phase 2 | 2019-11-15 |
| Unknown | PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study Small-cell Lung Cancer | Phase 3 | 2019-07-01 |
| Unknown | Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma Stage II, III, Nasopharyngeal Squamous Cell Carcinoma, Induction Chemotheray | Phase 2 / Phase 3 | 2019-06-15 |
| Unknown | PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer Extensive-stage Small Cell Lung Cancer, Radiotherapy, Immunotherapy | Phase 1 | 2019-06-01 |
| Unknown | Nimotuzumab Combined With VMAT in Elderly Patients With Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2019-05-01 |
| Unknown | Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer Breast Cancer | Phase 2 | 2019-04-19 |
| Unknown | Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer Breast Cancer | Phase 2 | 2019-04-19 |
| Unknown | Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer Metastatic Triple-Negative Breast Cancer | Phase 2 | 2019-04-11 |
| Unknown | Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Canc HER2-positive Breast Cancer | Phase 2 | 2019-03-11 |
| Unknown | Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With Oligometa Metastatic Colorectal Cancer | Phase 2 | 2019-03-01 |
| Unknown | The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Triple Negative Breast Cancer | Phase 3 | 2019-02-22 |
| Unknown | A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | 2019-02-20 |
| Unknown | Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer Breast Cancer | — | 2019-02-14 |
| Unknown | Optical Assessment on Brain Death Via a Oxygen Supply Procedure Brain Death | — | 2019-02-11 |
| Unknown | Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer Locally Advanced Pancreatic Cancer | Phase 2 | 2019-02-01 |
| Unknown | Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer Lung Cancer, Esophageal Cancer | — | 2019-02-01 |
| Unknown | TKI Followed by Thoracic Radiotherapy for Stage IV EGFR Mutant NSCLC Non-Small Cell Lung Cancer Metastatic | N/A | 2019-01-01 |
| Unknown | A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast C Breast Cancer, Brain Metastases | Phase 2 | 2018-12-22 |
| Unknown | HFSRT With Concurrent TMZ for Large BMs Brain Metastases, Chemotherapy, Radiotherapy | Phase 3 | 2018-12-03 |
| Recruiting | Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Esophageal Cancer | Phase 3 | 2018-11-01 |
| Unknown | GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma Tumor, Solid, Lymphoma | Phase 1 | 2018-11-01 |
| Unknown | Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Breast Cancer | Phase 2 | 2018-11-01 |
| Unknown | Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ) Breast Cancer, HER2-positive Breast Cancer | Phase 2 | 2018-11-01 |
| Completed | Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinom Advanced Hepatocellular Carcinoma | Phase 1 | 2018-10-11 |
| Unknown | Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma Recurrent Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | 2018-09-18 |
| Unknown | Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer Recurrent or Metastatic Breast Cancer | — | 2018-09-17 |
| Unknown | Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC NSCLC, Adenocarcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2018-08-15 |
| Unknown | Maintenance Treatment of Chidamide in Stage IV or Relapsed/Refractory Extranodal NK/T-cell Lymphoma Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | 2018-08-01 |
| Unknown | SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Canc Esophageal Squamous Cell Carcinoma | Phase 2 | 2018-07-31 |
| Unknown | Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorecta Colo-rectal Cancer | Phase 1 / Phase 2 | 2018-05-26 |
| Completed | Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma Lymphoid Neoplasm | — | 2018-05-10 |
| Completed | A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen fo Metastatic Colorectal Cancer | Phase 2 | 2018-05-01 |
| Unknown | Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer Platinum-resistant Recurrent Ovarian Cancer | Phase 2 | 2018-03-22 |
| Completed | Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC Vomiting, Nausea Post Chemotherapy, Head Neck Cancer | Phase 2 | 2018-03-01 |
| Unknown | Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Experimental | Phase 2 | 2018-01-25 |
| Unknown | Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine Poliomyelitis | Phase 3 | 2018-01-04 |
| Unknown | A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer Hormone Receptor Positive Advanced Breast Cancer | Phase 2 | 2017-12-12 |
| Unknown | Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3 Esophageal Neoplasms | Phase 3 | 2017-12-01 |
| Unknown | Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer Carcinoma, Small Cell, Lung Neoplasms | N/A | 2017-12-01 |
| Unknown | The Phase IVd of Inactivated Enterovirus 71 Vaccine Hand, Foot and Mouth Disease (HFMD) | Phase 4 | 2017-09-14 |
| Unknown | Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer | Phase 3 | 2017-09-01 |
| Unknown | Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer Small-cell Lung Cancer | Phase 3 | 2017-07-20 |
| Unknown | Factors Influencing Cancer Patients Participation in Clinical Trials in China. Cancer | — | 2017-07-15 |
| Unknown | A Clinical Study of Apatinib in Patients With Local Progressive/Metastatic Refractory Thyroid Cancer Refractory Cancer | Phase 2 | 2017-07-01 |
| Unknown | The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell) Hand, Foot and Mouth Disease (HFMD) | Phase 4 | 2017-06-22 |
| Completed | Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 Esophagus Cancer, Chemoradiation, Chemotherapy Effect | — | 2017-06-01 |
| Unknown | A Hospital Based Survey on Lung Cancer Related-pain in Northern China Cancer Pain, Lung Cancer | — | 2017-06-01 |
| Completed | Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer Breast Cancer | Phase 2 | 2017-05-01 |
| Unknown | How do Super Lean Subjects Keep Resistant to Body Weight Gain? Thinness, Health Behavior, Genetics | — | 2017-04-06 |
| Completed | Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery Breast Cancer Female | N/A | 2017-01-01 |
| Unknown | A Comparison of the Ambu®AuraGain™ and the Laryngeal Mask Airway Supreme™ in Normal Airway Patients Supraglottic Airway | N/A | 2017-01-01 |
| Unknown | Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC) Small Cell Lung Cancer | Phase 2 | 2016-12-01 |
| Unknown | High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC Carcinoma, Non-Small-Cell Lung | Phase 2 | 2016-11-01 |
| Unknown | Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation Non-small Cell Lung Cancer | Phase 2 | 2016-11-01 |
| Unknown | A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Sub Extrapancreatic Neuroendocrine Tumor | Phase 2 | 2016-10-01 |
| Completed | Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esopha Esophagus Cancer, Esophagogastric Junction Cancer, Radiotherapy; Complications | Phase 2 / Phase 3 | 2016-10-01 |
| Unknown | A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Sub Pancreatic Neuroendocrine Tumor | Phase 2 | 2016-10-01 |
| Completed | Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Rectal Neoplasms Malignant | Phase 2 | 2016-09-01 |
| Unknown | The Phase IVa of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) Safety of Inactivated EV71 Vaccine, Immunization of Inactivated EV71 Vaccine | Phase 4 | 2016-09-01 |
| Unknown | Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy Chemotherapeutic Toxicity, Malignant Tumor, Liver Injury | — | 2016-07-01 |
| Unknown | Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer Breast Cancer | Phase 2 | 2016-06-01 |
| Unknown | Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma Esophageal Neoplasms | Phase 2 | 2016-06-01 |
| Unknown | Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer Gastric Cancer, Chemoradiation | Phase 1 / Phase 2 | 2016-05-01 |
| Unknown | A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast Advanced Breast Cancer | — | 2016-04-01 |
| Unknown | Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients Metastatic Breast Cancer | Phase 2 | 2016-04-01 |
| Unknown | Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC Carcinoma, Small Cell, Lung Neoplasms | Phase 3 | 2016-02-01 |
| Completed | FSRT Combined With TMZ for Large BMs: a PSM Study Brain Metastases, Radiotherapy, Chemotherapy | — | 2016-01-01 |
| Unknown | Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer Anal Cancer | Phase 2 | 2015-12-02 |
| Unknown | Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients Breast Cancer | Phase 2 | 2015-12-01 |
| Unknown | Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer Triple Negative Breast Cancer | Phase 3 | 2015-10-01 |
| Unknown | Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type | Phase 2 | 2015-09-01 |
| Unknown | Purified Inactivated Japanese Encephalitis Vaccine Japanese Encephalitis Virus Disease | Phase 3 | 2015-09-01 |
| Completed | The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents Acute Lymphoid Leukemia | Phase 4 | 2015-09-01 |
| Completed | Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer Gastric Cancer | Phase 2 | 2015-08-01 |
| Unknown | Optimization of Preoperative Treatment in Locally Advanced Rectal Cancer Cancer, Rectum | Phase 3 | 2015-08-01 |
| Unknown | Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection Hepatocellular Carcinoma | N/A | 2015-08-01 |
| Unknown | A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Loca Gastric Cancer | Phase 3 | 2015-07-01 |
| Unknown | Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EG Gastric Adenocarcinoma | Phase 3 | 2015-07-01 |
| Completed | Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2015-05-01 |
| Unknown | The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Che Breast Cancer, Lung Cancer | N/A | 2015-05-01 |
| Unknown | S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Can Breast Cancer Recurrent | Phase 2 | 2015-04-01 |
| Unknown | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatm Esophageal Cancer | Phase 3 | 2015-04-01 |
| Completed | Prevention of OM-85 on Bronchiectasis Exacerbation Bronchiectasis With Acute Exacerbation | Phase 4 | 2015-03-01 |
| Unknown | Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Esophageal Cancer | Phase 3 | 2015-01-01 |
| Unknown | Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy Esophageal Cancer | — | 2015-01-01 |
| Completed | Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcino Esophageal Neoplasms | Phase 1 / Phase 2 | 2015-01-01 |
| Unknown | Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenop Breast Cancer | — | 2015-01-01 |
| Unknown | Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Invo Esophageal Cancer | N/A | 2015-01-01 |
| Unknown | Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial Esophageal Neoplasms | Phase 3 | 2014-12-01 |
| Unknown | Everolimus trIal for Advanced prememopausaL Breast Cancer Patients Metastatic Breast Cancer | Phase 2 | 2014-12-01 |
| Unknown | Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer Breast Cancer | Phase 2 | 2014-10-01 |
| Completed | Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases Brain Metastases | N/A | 2014-09-01 |
| Unknown | Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer Esophageal Carcinoma | Phase 3 | 2014-09-01 |
| Unknown | New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Ca Hypopharyngeal Cancer | Phase 2 | 2014-09-01 |
| Unknown | Tomotherapy for Refractory Brain Metastases Brain Metastases | N/A | 2014-09-01 |
| Completed | Tomotherapy for Leptomeningeal Metastases Leptomeningeal Metastasis | N/A | 2014-09-01 |
| Unknown | Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma Lymphoma | N/A | 2014-08-01 |
| Terminated | Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer Advanced Cancer | Phase 1 | 2014-05-01 |
| Unknown | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer Colorectal Cancer | Phase 2 | 2014-03-01 |
| Unknown | Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastase Stage IV Rectal Cancer, Liver Metastasis, Resectable | Phase 2 | 2014-01-01 |
| Unknown | Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer Breast Cancer, Neoadjuvant Chemotherapy | Phase 2 | 2014-01-01 |
| Unknown | Trial of Using SIB-IMRT in Preoperative Radiotherapy for Locally Advanced Rectum Cancer Rectal Cancer | Phase 2 | 2014-01-01 |
| Unknown | A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer Stomach Neoplasms, Chemoradiotherapy, Adjuvant, Radiotherapy, Intensity-Modulated | Phase 2 | 2014-01-01 |
| Completed | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcin Stomach Neoplasms, Neoadjuvant Therapy, Chemoradiotherapy | Phase 2 | 2014-01-01 |
| Unknown | Treatment Protocol of Child SAA With the Injection of Mesenchymal Stem Cells（Umbilical Cord Derived） Complications of Organ Transplant Stem Cells Umbilical Cord | Phase 4 | 2013-10-01 |
| Terminated | First Line Chemotherapy for Advanced Cancer Gastric Cancer | Phase 2 | 2013-09-01 |
| Unknown | Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer Squamous Cell Carcinoma of Lung | Phase 2 | 2013-09-01 |
| Unknown | Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma Carcinoma, Hepatocellular | Phase 1 | 2013-09-01 |
| Unknown | Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cance Breast Cancer | Phase 2 | 2013-09-01 |
| Unknown | Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma Thymoma | Phase 3 | 2013-07-01 |
| Unknown | The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era o Nasopharyngeal Carcinoma | Phase 3 | 2013-04-01 |
| Unknown | Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen Cancer, Lung Cancer | Phase 2 | 2013-03-01 |
| Completed | The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT Nasopharyngeal Neoplasms | Phase 2 | 2013-03-01 |
| Completed | Study on Blood Glucose Variations in Tumor Patients Before and After Total Parenteral Nutrition Cancer, Surgery, Nutrition Related Cancer | — | 2013-01-01 |
| Unknown | Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer Metastatic Breast Cancer | Phase 2 | 2012-11-01 |
| Unknown | The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer Rectal Cancer, Gastric Cancer, Bone Marrow Toxicity | — | 2012-11-01 |
| Completed | Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Ca Cervical Cancer | N/A | 2012-11-01 |
| Unknown | Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma; Esophageal Neoplasm, Esophageal Cancer TNM Staging Primary Tumor (T) T2, Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Phase 3 | 2012-10-01 |
| Unknown | Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Canc Locally Advanced Malignant Neoplasm | Phase 2 | 2012-10-01 |
| Unknown | Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent, B-cell Childhood Acute Lymphoblastic Leukemia | Phase 4 | 2012-10-01 |
| Unknown | Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | 2012-09-01 |
| Unknown | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2012-03-01 |
| Unknown | Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Dise Chronic Graft Versus Host Disease | Phase 2 / Phase 3 | 2012-02-01 |
| Unknown | A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity Rectal Cancer | Phase 2 | 2012-02-01 |
| Unknown | Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer Breast Cancer | Phase 2 | 2011-12-01 |
| Unknown | Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locall Lung Cancer | Phase 2 | 2011-12-01 |
| Unknown | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer Breast Cancer | Phase 2 | 2011-12-01 |
| Unknown | Clinical Study of Albumin-bound Paclitaxel Plus Nedaplatin in Cervical Cancer Uterine Cervical Cancer | Phase 2 | 2011-11-01 |
| Completed | A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors Solid Tumors | Phase 1 | 2011-11-01 |
| Completed | Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases Brain Metastases | Phase 2 | 2011-10-01 |
| Unknown | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Ca Colorectal Cancer | Phase 2 | 2011-10-01 |
| Unknown | Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients Gastric Cancer | Phase 2 | 2011-10-01 |
| Unknown | Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer Breast Neoplasms | Phase 2 | 2011-07-01 |
| Unknown | Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men HPV Infection, HIV Infection, Syphilis | — | 2011-07-01 |
| Completed | The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer Stomach Neoplasms | Phase 2 | 2011-06-01 |
| Completed | Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinic Esophageal Cancer | Phase 2 | 2011-06-01 |
| Unknown | SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer Gastric Cancer | Phase 1 / Phase 2 | 2011-06-01 |
| Unknown | The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC Breast Cancer | Phase 3 | 2011-05-01 |
| Completed | Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer Gastric Cancer | Phase 2 | 2011-04-01 |
| Completed | Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer Rectal Neoplasms | Phase 1 | 2011-01-01 |
| Completed | Observational Study on the Patients With Rectal Cancer Rectal Cancer, Adjuvant Chemoradiotherapy, Neoadjuvant Chemoradiotherapy | — | 2011-01-01 |
| Unknown | GDP in Frontline Chemotherapy for Patients With PTCL-NOS Lymphoma, T-Cell, Peripheral | Phase 2 | 2011-01-01 |
| Unknown | Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia Severe Aplastic Anemia | Phase 4 | 2010-12-01 |
| Unknown | Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients Metastatic Breast Cancer | Phase 1 | 2010-11-01 |
| Completed | Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients Rectal Neoplasms | Phase 1 | 2010-11-01 |
| Completed | A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer Gastrointestinal Neoplasms, Gastric Cancer | Phase 1 | 2010-11-01 |
| Completed | Sequence of Radiation and Targeted Therapy in Brain Metastases The Optimal Sequence of Radiotherapy and Systematic Tyrosine Kinase Inhibitors in Treating Brain Metastases | — | 2010-10-01 |
| Unknown | Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemorad Rectal Cancer | — | 2010-10-01 |
| Completed | Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer Extensive-stage Small Cell Lung Cancer | Phase 2 | 2010-07-01 |
| Unknown | Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer ( Carcinoma, Invasive Ductal, Breast | Phase 3 | 2010-07-01 |
| Unknown | Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China HPV Infections, Precancerous Disease of the Cervix, Cervical Cancer | Phase 4 | 2010-06-01 |
| Completed | Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma Stage I/II Extranodal NK/T-cell Lymphoma | Phase 2 | 2010-06-01 |
| Completed | Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer Locally Advanced Malignant Neoplasm | Phase 4 | 2010-06-01 |
| Completed | The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2010-05-01 |
| Unknown | Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer Gastric Cancer, Concurrent Chemoradiotherapy | Phase 2 | 2010-05-01 |
| Unknown | Regimens Comparison for Breast Cancers of Positive Lymph Nodes Breast Cancer | Phase 3 | 2010-05-01 |
| Unknown | 30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Ch Lymphoma, Large B-Cell, Diffuse | Phase 3 | 2010-04-01 |
| Completed | Effect of Montelukast on the Airway Remodeling Asthma | Phase 4 | 2010-01-01 |
| Completed | Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma Stomach Neoplasms | Phase 2 | 2009-10-01 |
| Completed | The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV) Poliomyelitis | Phase 2 | 2009-07-01 |
| Completed | Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-neg Breast Cancer | Phase 2 / Phase 3 | 2009-06-01 |
| Completed | Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer Thoracic Neoplasms, Non-small Cell Lung Cancer | Phase 3 | 2009-02-18 |
| Unknown | A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2008-11-01 |
| Completed | The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains Poliomyelitis | Phase 1 | 2008-08-01 |
| Completed | A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cance Breast Cancer | Phase 3 | 2008-06-01 |
| Terminated | Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes Breast Cancer | Phase 3 | 2008-06-01 |
| Unknown | Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer Rectal Neoplasms | — | 2008-04-01 |
| Completed | Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma Hepatocellular Cancer | N/A | 2008-01-01 |
| Unknown | Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Can Triple Negative Breast Cancer | Phase 2 | 2008-01-01 |
| Completed | Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell C Esophageal Cancer | Phase 2 | 2007-12-01 |
| Completed | Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma Esophageal Neoplasms | Phase 1 / Phase 2 | 2007-07-01 |
| Completed | Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-S Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2007-05-01 |
| Unknown | A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin Esophageal Cancer | Phase 2 | 2007-01-01 |
| Unknown | Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcino Rectal Neoplasms | Phase 2 | 2006-01-01 |
| Completed | A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy Cancer | Phase 3 | 2006-01-01 |
| Completed | Endoscopic Screening on Esophageal Cancer Esophageal Squamous Cell Carcinoma | N/A | 1999-11-01 |
| Completed | Felodipine Event Reduction Study Hypertension | N/A | 1998-04-01 |
| Available | Phase I Study of Sorafinib With Folfox4 as First-line Treatment in Advanced/Metastatic Gastric Cancer Gastric Cancer. | — | — |